Target intelligence / Profile preview

NADH dehydrogenase [ubiquinone] iron-sulfur protein chain (NDUFS (generic), or NDUFS1, NDUFS4, NDUFS6, NDUFS8, etc. for specific subunits)

Target
NDUFS (generic), or NDUFS1, NDUFS4, NDUFS6, NDUFS8, etc. for specific subunits
Molecular classification
Enzyme, Iron-sulfur protein, Mitochondrial Complex I subunit
01

Overview

NADH dehydrogenase [ubiquinone] iron-sulfur proteins comprise a series of essential subunits within mitochondrial Complex I, the first enzyme complex of the electron transport chain. These proteins catalyze electron transfer from NADH to ubiquinone via iron-sulfur clusters embedded in the protein subunits, contributing to the generation of the proton gradient used for ATP synthesis. Several specific subunits exist (e.g., NDUFS1, NDUFS4, NDUFS6, NDUFS8), each encoded by different nuclear genes and responsible for electron transfer or Complex I assembly. Mutations in these subunits are associated with mitochondrial diseases like Leigh syndrome and other dysfunctions involving oxidative phosphorylation. Complex I is a crucial metabolic enzyme and a validated drug target in contexts like neurodegeneration and metabolic diseases.

Other names
Complex I iron-sulfur proteinNADH:ubiquinone oxidoreductase iron-sulfur proteinNDUFS (plus specific numbers: NDUFS1, NDUFS4, etc.)CI-13kD-A (for NDUFS6)CI-18 (for NDUFS4)CI-23k (for NDUFS8)TYKY (NDUFS8)
02

Mechanism of action

Inhibition of Complex I (blocks electron transfer, reduces ATP generation, can trigger cell death); Modulation of redox/ROS balance (by altering electron flow)

03

Biological functions

Electron transportCellular respirationATP production (oxidative phosphorylation)Cellular redox homeostasis
04

Disease associations

Neurodegenerative disease (e.g., Leigh syndrome)Mitochondrial diseaseCardiovascular disease (by association with mitochondrial dysfunction)Other (potential cancer and metabolic disorder involvement)
05

Safety considerations

Complex I inhibition may lead to cellular energy deficit, lactic acidosis, neurotoxicity, and organ dysfunctionOff-target effects on normal mitochondrial functionPotential for long-term neurodegeneration if chronically inhibited
06

Interacting drugs

NADH (substrate)

2 more in the full profile.

07

Biomarkers

Mutations (e.g., in NDUFS4, NDUFS8) indicate risk or presence of Leigh syndrome or mitochondrial disordersComplex I activity (measured in patient cells as a diagnostic marker)

Beyond the preview

Go deeper on NADH dehydrogenase [ubiquinone] iron-sulfur protein chain (NDUFS (generic), or NDUFS1, NDUFS4, NDUFS6, NDUFS8, etc. for specific subunits).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH dehydrogenase [ubiquinone] iron-sulfur protein chain (NDUFS (generic), or NDUFS1, NDUFS4, NDUFS6, NDUFS8, etc. for specific subunits).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call